Shares of Co-Diagnostics Inc (CODX) are trading 7% higher at a price of $6.81 at the time of this writing.

Co-Diagnostics Inc has been trading between a 52-week high of $11.82 and a 52-week low of $3.66. The stock has a market cap of $230 Million.

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests
InvestorPlace 07-11-22

CODX stock spikes on shipments of monkeypox test (NASDAQ:CODX)
Seeking Alpha 07-11-22

Why Co-Diagnostics Stock Is Rising Today
The Motley Fool 07-11-22

Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
Co-Diagnostics 07-11-22

Why Co-Diagnostics Is Running Higher Today
The Motley Fool 07-05-22